Who is the CEO of HAEMATO AG?

Mr. Patrick Brenske is a business executive who currently serves as the CEO of HAEMATO AG.

What is the Revenue Growth of HAEMATO AG?

Revenue growth data for HAEMATO AG is currently unavailable.

What is HAEMATO AG operating Margin?

HAEMATO AG operating margin is 3.34% which shows how much profit HAEK.DE earns from each dollar of sales, after subtracting the direct costs tied to generating that revenue.

In which market sector does HAEMATO AG operate?

HAEMATO AG falls under the Healthcare sector which thrives across multiple industries. It stays competitive through its diverse product lineup, which spans computer hardware, tech gadgets, video streaming services, and cloud computing solutions.

What is HAEMATO AG revenue growth?

Revenue growth data for HAEMATO AG is currently unavailable.

HAEMATO AG

HAEK.DE•XETRA

HealthcareDrug Manufacturers - Specialty & Generic

$21.40

$-0.40(-1.83%)

HAEMATO AG (HAEK.DE) Stock Overview

Explore HAEMATO AG’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for HAEK.DEStats details for HAEK.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations data is not available for HAEK.DEAnalyst Recommendations details for HAEK.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.

CEO

Mr. Patrick Brenske

Employees

Headquarters

Lilienthalstrasse 5c, Schönefeld

Founded

2007